757-86039-71993
3 vaccinations
3 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-10-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Dose 2 — Pfizer-BioNTech
-
2021-10-05
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-06
Registered in v-safe
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
-
2021-10-26
Survey response — day 21, dose 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: Slight congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
-
2022-04-05
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Diarrhoea, Headache, Nausea, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend schoolFree text: Covid positive, headache, nausea, diarrhea, cough, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Survey response — 12 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Off and on URIsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | No |
| 2 | 2021-02-26 | Pfizer-BioNTech | No |
| 3 | 2021-10-05 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-05 | Successful 2022-10-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 21, dose 3
Symptoms: Slight congestion
Release 11 — 6 months, dose 3
Symptoms: Covid positive, headache, nausea, diarrhea, cough, sore throat
Release 12 — 12 months, dose 3
Symptoms: Off and on URIs
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release